ClinicalThought

Share

Program Content

Activities

  • BTKis for CLL
    BTK Inhibitor Therapy for CLL: An International Perspective
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 28, 2023

    Expires: March 27, 2024

Faculty

cover img faculity

Stephan Stilgenbauer, MD

Medical Director, Comprehensive Cancer Center Ulm
Head, Early Clinical Trials Unit
Head, Division of CLL
Department of Internal Medicine III
Comprehensive Cancer Center Ulm
University Medical Center Ulm
Ulm, Germany

Provided by

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca